This Project Grant award of $654,475 from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, will support research to characterize the impact of gender-affirming hormone therapy (GHT) on pain and pain-related symptoms in gender minority (GM) adults. The key objectives are to: 1) Characterize the trajectory of pain and pain-related symptoms in GM adults taking GHT; 2) Perform quantitative sensory testing and functional brain imaging to examine the mechanisms underlying changes in pain and sensory sensitivity associated with GHT; and 3) Conduct qualitative studies on how GHT affects gender affirmation, psychological well-being, and the experience of pain. The University of Kansas Medical Center Research Institute, Inc. is the prime awardee, and they will collaborate with a sub-awardee, The Ohio State University, to execute the qualitative research component of the study.
Mod # | Description | Reason For Modification | Federal Obligation (Click to sort descending) | Date (Click to sort ascending) |
|---|---|---|---|---|
| Not listed | $654.5k | 9/17/24 |
Grant Number | Description | Subgrantee | Prime Award | Dollars Obligated (Click to sort descending) | Updated At (Click to sort ascending) |
|---|---|---|---|---|---|
SUB00001367S | Regents Of The University Of Michigan | Project Grant R01NS135833 | $67.3k | 5/9/25 | |
SUB00001366S | The Ohio State University | Project Grant R01NS135833 | $43.0k | 4/21/25 |